Long-Acting Injectable ART: Coverage and Cost-Sharing Considerations
Blog updated 12/22/2022
Blog updated 12/22/2022
Overview of the policies, procedures, and protocols developed by an ADAP and Part C clinic to establish access to antiretrovirals, including long-acting cabotegravir/rilpivirine.
Resource (Conference Presentation) updated 09/14/2023
Among people with HIV who also inject drugs, an estimated 80 to 90 percent are coinfected with Hepatitis C (HCV.) This panel will provide updates on screening and referral activities and demonstrate how community and city partners are overcoming barriers to HCV care among PWID.
Resource (Conference Presentation) updated 09/14/2023
Access these tools on integrating hepatitis screening and treatment within HIV care programs.
Blog updated 05/20/2024
Blog updated 03/28/2024